A team from the Biopharmaceutical Development Program is developing a new autologous cell therapy line that uses engineered chimeric antigen receptor T cells to treat acute myeloid leukemia, a particularly aggressive form of pediatric blood cancer. This foray into cell immunotherapy represents a new avenue of research and development for the BDP, which has traditionally focused on biologics to fight cancer, HIV, and rare diseases.

Oompa Loompas set up shop in the hallways of Building 430. Building 362 shimmered with holiday lights and glitzy casino décor. Someone pitched a tent in the Scientific Library. For the sixth straight year, the Recreation and Welfare Club’s Holiday Decorating Contest transformed parts of NCI at Frederick and the Frederick National Laboratory into whimsical scenes of festive cheer.

Do you want to improve the quality, sharing, and re-use of biomedical data produced from your research? Join the Scientific Library in February and March for the Data Science Winter Webinar Series.

Euna Yoo, Ph.D., has found what she calls “the perfect place” to begin her career as an independent researcher—the Chemical Biology Laboratory at NCI at Frederick. The 11-year-old laboratory is an internationally recognized program that performs basic science to develop and apply chemical tools, methods, and materials to understand and alter biological processes involved in cancer and AIDS.

Nearly two decades ago, NIH’s first female director formed a task force to evaluate the status of women scientists in the Intramural Research Program. The resulting report led to the creation of the Women Scientist Advisors, a group that counsels senior leaders in each institute and center on issues facing women in the sciences.